Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | GPR119 | Q8TDV5 | 7/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18383165 | 0.88 | NR1H2 (0.44) | NR1H2USP2SMN1; SMN2GPR119CHRM2 | |
| SCHEMBL9962390 | 0.88 | NR1H2 (0.44) | NR1H2USP2SMN1; SMN2GPR119CHRM2 | |
| SCHEMBL16192303 | 0.87 | NR1H2 (0.57) | NR1H2USP2SMN1; SMN2GPR119CHRM2 | |
| SCHEMBL66134 | 0.87 | GPR119 (0.48) | USP2SMN1; SMN2GPR119HPGDRECQL | |
| SCHEMBL372088 | 0.87 | NR1H2 (0.57) | NR1H2USP2SMN1; SMN2GPR119CHRM2 | |
| SCHEMBL66145 | 0.87 | GPR119 (0.48) | USP2SMN1; SMN2GPR119HPGDRECQL | |
| SCHEMBL11957185 | 0.87 | NR1H2 (0.57) | NR1H2USP2SMN1; SMN2GPR119CHRM2 | |
| SCHEMBL330785 | 0.87 | GPR119 (0.48) | USP2SMN1; SMN2GPR119HPGDRECQL | |
| SCHEMBL20567011 | 0.87 | NR1H2 (0.57) | NR1H2USP2SMN1; SMN2GPR119CHRM2 | |
| SCHEMBL19597436 | 0.87 | NR1H2 (0.57) | NR1H2USP2SMN1; SMN2GPR119CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 771 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103775-A1 | PROCESS FOR LEACHING METAL SULFIDES WITH REAGENTS HAVING THIOCARBONYL FUNCTIONAL GROUPS | JETTI RESOURCES, LLC (US) | 2026-04-16 | — | — | US | claimed |
| US-12416066-B2 | Process for leaching metal sulfides with reagents having thiocarbonyl functional groups | JETTI RESOURCES, LLC (US) | 2025-09-16 | — | — | US | claimed |
| US-20250092487-A1 | METHODS FOR LIBERATING PRECIOUS METALS USING A REAGENT HAVING A THIOCARBONYL FUNCTIONAL GROUP | JETTI RESOURCES, LLC (US) | 2025-03-20 | — | — | US | claimed |
| US-20240336991-A1 | PROCESS FOR LEACHING METAL SULFIDES WITH REAGENTS HAVING THIOCARBONYL FUNCTIONAL GROUPS | JETTI RESOURCES, LLC (US) | 2024-10-10 | — | — | US | claimed |
| US-12049681-B2 | Process for leaching metal sulfides with reagents having thiocarbonyl functional groups | JETTI RESOURCES, LLC (US) | 2024-07-30 | — | — | US | claimed |
| US-20240167121-A1 | PROCESS FOR LEACHING METAL SULFIDES WITH REAGENTS HAVING THIOCARBONYL FUNCTIONAL GROUPS | JETTI RESOURCES, LLC (US) | 2024-05-23 | — | — | US | claimed |
| US-11859263-B2 | Process for leaching metal sulfides with reagents having thiocarbonyl functional groups | JETTI RESOURCES, LLC (US) | 2024-01-02 | — | — | US | claimed |
| WO-2022245731-A1 | METHODS FOR LIBERATING PRECIOUS METALS USING A REAGENT HAVING A THIOCARBONYL FUNCTIONAL GROUP | JETTI RESOURCES, LLC (US) | 2022-11-24 | — | — | WO | claimed |
| CN-107532229-B | Process for leaching metal sulphides with an agent having a thiocarbonyl function | 不列颠哥伦比亚大学 | 2021-10-08 | — | — | CN | claimed |
| US-20200181737-A1 | Process for Leaching Metal Sulfides with Reagents Having Thiocarbonyl Functional Groups | JETTI RESOURCES, LLC | 2020-06-11 | — | — | US | claimed |
| US-20200149131-A1 | Process for Leaching Metal Sulfides with Reagents Having Thiocarbonyl Functional Groups | JETTI RESOURCES, LLC | 2020-05-14 | — | — | US | claimed |
| US-12637451-B2 | Amino quinazoline derivatives as P2X3 inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2026-05-26 | — | — | US | disclosed |
| US-12637428-B2 | Isoquinoline derivatives as SIK2 inhibitors | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2026-05-26 | — | — | US | disclosed |
| US-12630530-B2 | FGFR inhibitor compound and use thereof | HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2026-05-19 | — | — | US | disclosed |
| EP-4214343-B1 | EXTRACTING BASE METALS USING A WETTING AGENT AND A THIOCARBONYL FUNCTIONAL GROUP REAGENT | JETTI RESOURCES LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-0632808-A1 | ANTIVIRAL PEPTIDES | Pfizer Limited (GB) | 1995-01-11 | — | — | EP | disclosed |
| CN-1077716-A | ANTIVIRAL PEPTIDES | PFIZER (US) | 1993-10-27 | — | — | CN | disclosed |
| EP-0500835-A1 | A NOVEL QUINOLONE CARBOXYLIC ACID DERIVATIVE. | DAE WOONG PHARMA (KR) | 1992-09-02 | — | — | EP | disclosed |
| WO-1992004342-A1 | A NOVEL QUINOLONE CARBOXYLIC ACID DERIVATIVE | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 1992-03-19 | — | — | WO | disclosed |
| WO-1992002521-A1 | 1-AZABICYCLO[3.2.0]HEPT-2-ENE-2-CARBOXYLIC ACID COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630530-B2 | FGFR inhibitor compound and use thereof | FGFR3, FGFR1, FGFR4 | NR1H2 872/4885USP2 4649/4885SMN1; SMN2 3320/4885 |
| US-12637428-B2 | Isoquinoline derivatives as SIK2 inhibitors | SIK2, SIK1, SIK3 | NR1H2 906/4885USP2 3178/4885SMN1; SMN2 925/4885 |
| US-20260103775-A1 | PROCESS FOR LEACHING METAL SULFIDES WITH REAGENTS HAVING THIOCARBONYL FUNCTIONAL GROUPS | TST, FECH, SLC6A12 | NR1H2 3564/4885USP2 2535/4885SMN1; SMN2 2893/4885 |
| US-12637451-B2 | Amino quinazoline derivatives as P2X3 inhibitors | P2RX3, P2RX1, P2RX7 | NR1H2 672/4885USP2 3723/4885SMN1; SMN2 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.